This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
How Strong Is the American Consumer, Really?
LSEG’s Jharonne Martis breaks down consumer spending, tariffs, and what discretionary vs. staples reveal about shopper health.
What the Markets Are Really Saying as Year-End Nears
From labor market shifts to global trade tensions, EquitySet CEO Tony Zipparo unpacks the forces moving markets today.
The 2026 Trends You Won’t Believe What People Are Searching for on Yelp
From grandma hobbies to wellness rooms and mahjong mania, Yelp’s hottest local searches reveal 2026's most unexpected trends.
The Card That Changed Collecting Forever: Why Logan Paul’s Pikachu Is Breaking the Market
Logan Paul and Ken Goldin break down the collectibles boom, rare Pokémon cards, auction strategy. Plus, Logan’s take on Jake Paul’s fight.
From Great Resignation to Great Stay: The Job Market Shifts
The U.S. job market is cooling as hiring slows and unemployment rises. ZipRecruiter economist Nicole Bachaud breaks down the trends shaping 2026.
"The Business Of Booze" Ep 3: Brooklyn Kura, Superbueno, Chacha Singsuwan
Across NYC's 3,800 bars are trailblazers redefining the industry. From Brooklyn sake to America's best bar, discover what's driving business behind the beverage
